This past week, Aurora announced that it had received approval from Health Canada to start producing soft gel capsules. And through a significant ownership in Capcium Inc., a company that manufactures soft gel products, Aurora plans to begin production immediately.
It also announced that CanniMed would be offering medical Marijuana capsules that are vegan, have no taste and can provide patients with consistent reliable medical effects. The company believes that this is a “game-changer” when it comes to the medical marijuana market.
In the release, Aurora CEO Terry Booth stated, “While many people continue to use dried buds for sickness relief, there is growing worldwide demand for different drug delivery technologies. Through CanniMed and our partnership with Capcium, we are well-positioned to lead in this sector of the Cannabis market
Why should this this matter to you?
Medical marijuana is a very appealing market with huge growth opportunities that have unfortunately still not been made manifest. And while much of the speculative reasoning being made these days circles around food and the possible power or ability that exists in the drink market, there‘s a lot more reach for medical marijuana products.
Healthcare is big business worldwide, and by having a discreet way for patients to consume medical marijuana, it will attract more people to try it, especially those that may feel more comfortable with taking a pill. Softgels are a popular choice when it comes to medical products, and with Aurora beginning production on this, it could lead to a lot more sales growth and expansion in the future.
Many investors may make disagree, saying that medical marijuana has been around for years and it has not gone anywhere, and that the real market is in recreational pot. While it‘s true that medical marijuana is not new, it still faces some major hurdles in development and safe delivery from both patients and healthcare professionals.
More studies need to be done to convince doctors of the usefulness of medical marijuana, as there‘s still a lot of doubt out there and many professionals wouldn‘t endorse the Cannabis therapy, which leaves it up to the patient to request it.
Bottom line
This is a big step in a process that Aurora has had its sights on when it made some big purchases in the past year, and the company is preparing to become a leader in the medical marijuana market. The (possible greatness or power) in this part/section is huge and while it may not be as exciting as recreational pot sales, it can provide for more growth as it‘ll be easier to enter more parts of the world where marijuana is still only permitted for medical purposes.
While Aurora Cannabis has struggled this year, positioning itself as the top medical marijuana company could be what it needs to prove it is the best pot stock to invest in.
C.M.M.A 